Live from the NIH registry
Studies recruiting near Richmond right now
Top 25 of 624 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
CJW Medical Center — Richmond, Virginia (1.9 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2
Phase 1, Phase 2
Interventional 10 participants sought
VCU — Richmond, Virginia (1.9 mi)
· Sponsor: AskBio Inc
His-Bundle Corrective Pacing in Heart Failure
Right Bundle-Branch Block, Heart Failure
N/A
Interventional 120 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: University of Rochester
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: Giselle Sholler
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Infant, Extremely Premature, Obstetric Labor, Premature
N/A
Observational 5,000 participants sought
Children's Hospital of Richmond — Richmond, Virginia (1.9 mi)
· Sponsor: The University of Texas Health Science Center, Houston
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 410 participants sought
VCU Massey Cancer Center — Richmond, Virginia (1.9 mi)
· Sponsor: AVEO Pharmaceuticals, Inc.
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
Any Solid Oral Medication
N/A
Interventional 200 participants sought
Virginia Cancer Center — Richmond, Virginia (1.9 mi)
· Sponsor: Dosentrx Ltd.
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
Chronic Graft-versus-host Disease (cGVHD)
Phase 2
Interventional 120 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Richmond, Virginia (1.9 mi)
· Sponsor: Sameek Roychowdhury
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Bon Secours Cancer Institute at St. Francis ( Site 0048) — Midlothian, Virginia (9.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Bon Secours Cancer Institute at St. Mary's Hospital — Richmond, Virginia (1.9 mi)
· Sponsor: Pfizer
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Pulmonary Hypertension, Interstitial Lung Disease
Phase 3
Interventional 344 participants sought
USA008 — Richmond, Virginia (1.9 mi)
· Sponsor: Insmed Incorporated
Impact of Food Assistance on Treatment Adherence and Clinical Outcomes in Food-Insecure Cancer Pts
Treatment Adherence
N/A
Interventional 350 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: Virginia Commonwealth University
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Post Operative Surgical Site Infection
Phase 3
Interventional 600 participants sought
Virginia Commonwealth University Medical Center — Richmond, Virginia (1.9 mi)
· Sponsor: Major Extremity Trauma Research Consortium
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Institute of Virginia — Richmond, Virginia (1.9 mi)
· Sponsor: Genentech, Inc.
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Schizophrenia, Bipolar I Disorder
Phase 3
Interventional 220 participants sought
Alkermes Investigational Site — Richmond, Virginia (1.9 mi)
· Sponsor: Alkermes, Inc.
Examining Lateralized Aspects of Motor Control Using Non-invasive Neural Stimulation
Motor Adaptation and Generalization, Posterior Parietal Cortex
N/A
Interventional 60 participants sought
Virginia Commonwealth University Medical Center — Richmond, Virginia (1.9 mi)
· Sponsor: Virginia Commonwealth University
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Bon Secours Richmond Community Hospital — Richmond, Virginia (1.9 mi)
· Sponsor: NRG Oncology
The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study
Ischemic Heart Disease (IHD), Cardiac Magnetic Resonance Imaging
N/A
Interventional 1,000 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: Brigham and Women's Hospital
Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
Opioid Use Disorder, Opioid Use
Phase 2
Interventional 100 participants sought
VCU Institute for Drug and Alcohol Studies — Richmond, Virginia (1.9 mi)
· Sponsor: Virginia Commonwealth University
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Colo-rectal Cancer
Phase 2
Interventional 79 participants sought
Virginia Commonwealth University - Massey — Richmond, Virginia (1.9 mi)
· Sponsor: NSABP Foundation Inc
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma
Asthma
Phase 2
Interventional 600 participants sought
WB Contracted Clinical Research Site — Richmond, Virginia (1.9 mi)
· Sponsor: Windward Bio
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Vitiligo, Non-Segmental Vitiligo (NSV)
Phase 2
Interventional 66 participants sought
Clinical Research Partners, LLC — Richmond, Virginia (1.9 mi)
· Sponsor: Eli Lilly and Company
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma
Phase 3
Interventional 562 participants sought
Bon Secours Saint Mary's Hospital — Richmond, Virginia (1.9 mi)
· Sponsor: SWOG Cancer Research Network
Cardiac Arrest - Ultrasound Detection of Occult Perfusion
Cardiac Arrest, Out-Of-Hospital, Hypotension
N/A
Observational 1,400 participants sought
VCU Health — Richmond, Virginia (1.9 mi)
· Sponsor: University of Massachusetts, Worcester